NHS able to delay rollout of expensive drugs under new rules


  • International Medical Press
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

New rules will allow NHS England to delay the rollout of expensive treatments even after approval by the National Institute of Health and Care Excellence (NICE).

Any drug likely to cost the NHS over £20 million per year will be subject to the slower rollout. This would allow more time for NHS E...